Stocks · News reference

RBC Capital Maintains Outperform on Charles River, Raises Price Target to $352

2026-11-05 18:48:37 UTCBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Fiscal.ai2026-11-05 19:03:26 UTC
Financial Institutions Adjust Price Targets for Charles River Laboratories Following Q3 Earnings
Multiple investment firms, including UBS, Jefferies, RBC, and Deutsche Bank, updated their price targets for Charles River Laboratories International, Inc. on November 5, 2026, following the company's third-quarter earnings report.
CRL
Fiscal.ai2026-11-05 14:31:58 UTC
Jefferies Adjusts Price Target on Charles River Laboratories International to $385 From $340
Investment firm Jefferies has increased its price target for Charles River Laboratories International, Inc. to $385 from the previous target of $340.
CRL
Benzinga2026-11-05 14:10:36 UTCBenzinga Newsdesk
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $400
CRL
Fiscal.ai2026-11-05 12:32:48 UTC
Charles River Laboratories International Price Target Updated by Analysts
Analysts have updated the 12-month price target for Charles River Laboratories International, Inc. to $333.43.
CRL
Benzinga2026-11-04 14:29:52 UTCBenzinga Newsdesk
Charles River Executive Says Overtime Goal Is To Cover Annual Cost Inflation Through Price Increases; Company Not Expecting A Pricing Benefit Until At Least H2 2027
CRL
Fiscal.ai2026-11-04 12:31:52 UTC
Charles River Laboratories Announces Third-Quarter 2026 Results
Charles River Laboratories International, Inc. released its financial results for the third quarter ended September 30, 2026.
CRL